Menopause is usually associated with an increase in body weight, a change in body composition
and fat distribution and a large number of cardio-metabolic changes, such as hypertension,
reduction of insulin-sensitivity and dyslipidaemia. The first-line strategy for these
complications is the modification of dietary habits and lifestyle in terms of physical
activity. Besides, there is also a growing interest in complementary therapies (i.e.
nutraceuticals) that can be used alone or in combination to achieve more consistent results.
In this context, preliminary evidence supports the potential role of some compounds of
vegetal origin such as berberine, chlorogenic acid and tocotrienols. However, in support of
their use, the evidence from good quality trials is limited.